A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Clinical trial NCT02132468 · COMPLETED

Trial details

NCT number: NCT02132468
Sponsor: Mateon Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2014-09-01
Primary completion: 2016-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.